Nuvalent, Inc. (NASDAQ:NUVL – Get Rating) insider Darlene Noci sold 1,000 shares of the stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $45.07, for a total value of $45,070.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. […]
Nuvalent, Inc. (NASDAQ:NUVL – Get Rating) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $45.25 and last traded at $44.68, with a volume of 76460 shares changing hands. The stock had previously closed at $43.08. Nuvalent Price Performance The firm has a 50-day moving average of […]
Nuvalent, Inc. (NASDAQ:NUVL – Get Rating) dropped 3% during trading on Tuesday . The stock traded as low as $42.52 and last traded at $42.65. Approximately 93,729 shares changed hands during trading, a decline of 61% from the average daily volume of 239,654 shares. The stock had previously closed at $43.97. Nuvalent Stock Performance The […]
Nuvalent, Inc. (NASDAQ:NUVL – Get Rating) shares hit a new 52-week high during trading on Thursday . The stock traded as high as $43.20 and last traded at $43.03, with a volume of 89333 shares traded. The stock had previously closed at $42.10. Nuvalent Stock Performance The stock’s 50-day simple moving average is $33.83 and […]
Nuvalent (NASDAQ:NUVL – Get Rating) and Morphic (NASDAQ:MORF – Get Rating) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership. Insider & Institutional Ownership 79.8% of Morphic shares are held by […]